Drug Discovery

Can the innate immune system be reprogrammed to fight cancer? Inmune Bio believes the answer is yes.

Georg Winter has cinched Eppendorf's 2019 Young European Scientist award.

SPaeDD, a collaborative effort between industry, academia and contractors, is helping to accelerate pediatric drug development in the UK..

Will the antibiotic apocalypse kill us all?

Will antibody drug conjugates live up to the ever-growing expectations surrounding them?

At the helm of SkinBioTherapeutics, Catherine O’Neill and her team are exploring the ways in which probiotic bacteria can be used topically.

Could blood cells provide the ideal environment to test new drugs for neuropsychiatric disorders?

Drug repurposing is in vogue, but it’s not always as easy as you think.

Could harnessing the power of artificial intelligence put an end to the leading cause of sight loss in the developed world?

Can synergistic combinations rejuvenate existing antibiotics in the fight against antibiotic resistance?